|
|
Article: BioVeris Licenses Exclusive Vaccine Rights From Baxter.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Through a technology license agreement, BioVeris Corp. attained exclusive rights to a portfolio of vaccines that could someday enter billion dollar global infectious disease markets.
The Gaithersburg, Md.-based company signed for the rights from Baxter Healthcare Corp., agreeing to pay a license fee, and possibly patent costs and milestone fees, as well as royalties. The milestones would be based on the initiation and completion of clinical trials and regulatory approvals. A minimum annual royalty to Deerfield, Ill.-based Baxter would start in 2010, but it is creditable against any other milestone payments and royalties.
BioVeris ...